Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Pharm (Weinheim) ; 355(11): e2200294, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35972839

ABSTRACT

Two new series of 1,3,4-oxadiazoles bearing pyridine and thiazole heterocycles (4a-h and 5a-h) were synthesized (2,5-disubstituted-1,3,4-oxadiazoles). The structures of these newly synthesized compounds were confirmed by 1 H nuclear magnetic resonance (NMR), 13 C NMR, high-resolution mass spectrometric and Fourier transform infrared spectroscopic methods. All these compounds were evaluated for their enzyme inhibitory activities against two cholinesterase enzymes, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). From the studies, we identified compounds 4a, 4h, 5a, 5d, and 5e as selective AChE inhibitors, with IC50 values ranging from 0.023 to 0.037 µM. Furthermore, docking studies of these compounds were performed at the active sites of their target enzymes. The molecular docking study showed that 5e possessed an ideal docking pose with interactions inside AChE.


Subject(s)
Butyrylcholinesterase , Cholinesterase Inhibitors , Cholinesterase Inhibitors/chemistry , Butyrylcholinesterase/metabolism , Acetylcholinesterase/metabolism , Molecular Docking Simulation , Molecular Dynamics Simulation , Structure-Activity Relationship , Oxadiazoles/pharmacology , Molecular Structure
SELECTION OF CITATIONS
SEARCH DETAIL
...